Clinical aspects of cmv infection after stem cell transplantation
- 31 May 2004
- journal article
- review article
- Published by Elsevier BV in Human Immunology
- Vol. 65 (5), 432-436
- https://doi.org/10.1016/j.humimm.2004.02.022
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trialBlood, 2003
- Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood productsBlood, 2003
- Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunityBlood, 2003
- Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantationBone Marrow Transplantation, 2002
- Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantationBlood, 2002
- Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomesBlood, 2001
- Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipientsBlood, 2001
- Cytomegalovirus pp65 Antigenemia after Autologous Marrow and Peripheral Blood Stem Cell TransplantationThe Journal of Infectious Diseases, 1996
- COMBINED FOSCARNET-GANCICLOVIR TREATMENT FOR CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION1Transplantation, 1996
- Failure of High-Dose Acyclovir to Prevent Cytomegalovirus Disease after Autologous Marrow TransplantationThe Journal of Infectious Diseases, 1995